Article

Transitions Academy helps enlighten industry leaders

Orlando, FL-More than 1,000 industry professionals journeyed from around the world to Disney's Yacht and Beach Club Resort for the 2007 Transitions Academy, Jan. 25 to 27.

Orlando, FL-More than 1,000 industry professionals journeyed from around the world to Disney's Yacht and Beach Club Resort for the 2007 Transitions Academy, Jan. 25 to 27.

Theme of the 11th annual academy was "Enlightened Leadership." At the opening general session, the international audience was welcomed by Dave Cole, general manager of the Americas, Transitions Optical Inc., and Jose Alves, general manager, Latin America, Transitions. According to Cole, "Part of being 'enlightened' is sharing that enlightenment with others. This 2007 academy is all about empowering our partners to better serve their customers using their own unique talents and credentials."

Next, Brett Craig, Transitions chief operating officer, told how this year's academy program would help bridge the gap between patient interest and action. Grady Lenski, Transitions director of strategy and commercial operations, spotlighted new programs and tools from Transitions Optical, including the new Transitions Healthy Sight for Life Fund, the Spin & Win sweepstakes, and an advertising partnership with "Wheel of Fortune."

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Mark Lobanoff, MD, on making the move to office-based surgery
Barsha Lal, PhD, discusses the way low dose atropine affects accommodative amplitude and dynamics at the 2025 ARVO meeting
(Image credit: Ophthalmology Times) NeuroOp Guru: When eye findings should prompt neuroimaging in suspected neuro-Behcet disease
At the Association for Research in Vision and Ophthalmology (ARVO) meeting, Katherine Talcott, MD, a retina specialist at Cleveland Clinic, shared her findings on EYP-1901 (EyePoint Pharmaceuticals) in the phase 2 DAVIO study.
Dr. Jogin Desai, founder of Eyestem Research, discusses his research at the Association for Research in Vision and Ophthalmology.
(Image credit: Ophthalmology Times) ASCRS 2025: Michael Rivers, MD, shares his takeaways as a panelist at the inaugural SightLine event
(Image credit: Ophthalmology Times) ASCRS 2025: Karl Stonecipher, MD, on LASIK outcomes using an aspheric excimer laser for high myopia
John Tan talks about an emergency triage framework for retinal artery occlusion at the 2025 Association for Research in Vision and Ophthalmology (ARVO) meeting.
Dr Robert Maloney at the 2025 Controversies in Modern Eye Care meeting
Wendy Lee, MD, MS, at Controversies in Modern Eye Care 2025.
© 2025 MJH Life Sciences

All rights reserved.